ACIU
Price
$1.65
Change
-$0.12 (-6.78%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
177.73M
19 days until earnings call
NAGE
Price
$6.01
Change
-$0.62 (-9.35%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
515.49M
32 days until earnings call
Ad is loading...

ACIU vs NAGE

Header iconACIU vs NAGE Comparison
Open Charts ACIU vs NAGEBanner chart's image
AC Immune SA
Price$1.65
Change-$0.12 (-6.78%)
Volume$2.18K
Capitalization177.73M
Niagen Bioscience
Price$6.01
Change-$0.62 (-9.35%)
Volume$1.06K
Capitalization515.49M
ACIU vs NAGE Comparison Chart
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. NAGE commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and NAGE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (ACIU: $1.77 vs. NAGE: $6.63)
Brand notoriety: ACIU and NAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 116% vs. NAGE: 56%
Market capitalization -- ACIU: $177.73M vs. NAGE: $515.49M
ACIU [@Biotechnology] is valued at $177.73M. NAGE’s [@Biotechnology] market capitalization is $515.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileNAGE’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • NAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, NAGE is a better buy in the long-term than ACIU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 3 TA indicator(s) are bullish while NAGE’s TA Score has 5 bullish TA indicator(s).

  • ACIU’s TA Score: 3 bullish, 4 bearish.
  • NAGE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NAGE is a better buy in the short-term than ACIU.

Price Growth

ACIU (@Biotechnology) experienced а -11.50% price change this week, while NAGE (@Biotechnology) price change was -10.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

ACIU is expected to report earnings on Apr 24, 2025.

NAGE is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($515M) has a higher market cap than ACIU($178M). NAGE YTD gains are higher at: 24.976 vs. ACIU (-34.444). NAGE has higher annual earnings (EBITDA): 9.21M vs. ACIU (-48.62M). ACIU has more cash in the bank: 165M vs. NAGE (44.5M). NAGE has less debt than ACIU: NAGE (2.65M) vs ACIU (5.43M). NAGE has higher revenues than ACIU: NAGE (99.6M) vs ACIU (27.3M).
ACIUNAGEACIU / NAGE
Capitalization178M515M35%
EBITDA-48.62M9.21M-528%
Gain YTD-34.44424.976-138%
P/E RatioN/A60.27-
Revenue27.3M99.6M27%
Total Cash165M44.5M371%
Total Debt5.43M2.65M205%
FUNDAMENTALS RATINGS
ACIU vs NAGE: Fundamental Ratings
ACIU
NAGE
OUTLOOK RATING
1..100
5189
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
9741
PRICE GROWTH RATING
1..100
9136
P/E GROWTH RATING
1..100
8298
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACIU's Valuation (54) in the Pharmaceuticals Major industry is in the same range as NAGE (82) in the Chemicals Specialty industry. This means that ACIU’s stock grew similarly to NAGE’s over the last 12 months.

NAGE's Profit vs Risk Rating (79) in the Chemicals Specialty industry is in the same range as ACIU (100) in the Pharmaceuticals Major industry. This means that NAGE’s stock grew similarly to ACIU’s over the last 12 months.

NAGE's SMR Rating (41) in the Chemicals Specialty industry is somewhat better than the same rating for ACIU (97) in the Pharmaceuticals Major industry. This means that NAGE’s stock grew somewhat faster than ACIU’s over the last 12 months.

NAGE's Price Growth Rating (36) in the Chemicals Specialty industry is somewhat better than the same rating for ACIU (91) in the Pharmaceuticals Major industry. This means that NAGE’s stock grew somewhat faster than ACIU’s over the last 12 months.

ACIU's P/E Growth Rating (82) in the Pharmaceuticals Major industry is in the same range as NAGE (98) in the Chemicals Specialty industry. This means that ACIU’s stock grew similarly to NAGE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUNAGE
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
83%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
86%
MACD
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
78%
Aroon
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
84%
View a ticker or compare two or three
Ad is loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with BDTX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
-5.85%
BDTX - ACIU
54%
Loosely correlated
-4.43%
ARCT - ACIU
36%
Loosely correlated
-7.01%
FHTX - ACIU
33%
Loosely correlated
-7.89%
RGNX - ACIU
33%
Poorly correlated
-5.39%
PRME - ACIU
32%
Poorly correlated
-10.06%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
-6.36%
MDGL - NAGE
37%
Loosely correlated
-2.24%
CRBU - NAGE
31%
Poorly correlated
-8.83%
ETNB - NAGE
29%
Poorly correlated
-4.59%
ACIU - NAGE
29%
Poorly correlated
-5.85%
FHTX - NAGE
28%
Poorly correlated
-7.89%
More